Emglif-M & Emglif MXR

Therapeutic Segment:
Anti-diabetic

Generic Name:
Empagliflozin/Metformin HCI

Description:
Emglif-M tablets contain two oral antihyperglycemic drugs used in the management of type 2 diabetes: empagliflozin and metformin hydrochloride.

Indication:
Emglif-M is a combination of empagliflozin and metformin hydrochloride indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin hydrochloride is appropriate. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.

Formulation:

• Tablets

Strength:

• 12.5mg/500mg
• 12.5mg/1000mg
• 12.5/1000mg

Pack Size:

• 14’s